Corvus Pharmaceuticals Inc Sustainability Reports
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of immune-modulating therapies and oncology medicines.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300I3AVJ8F75NCX65
FIGI: BBG009F0TGJ6
2 reports from 2017 to 2023
